Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-04-18 00:00:00 ET · period of report 2022-04-14 · accession 0001567619-22-008635 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-18 | 2022-04-14 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $37.46 | +10.0K | 345.0K | +3% | +$374.6K |
| D | 2022-04-18 | 2022-04-14 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | S - Sale+OE | $83.66 | -10.0K | 335.0K | -3% | -$836.6K |
| D | 2022-04-18 | 2022-04-14 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $0.00 | -10.0K | 75.0K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-14 | M | A | 10,000 | $37.46 | 344,983 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on December 9, 2021, as amended on March 11, 2022. Mr. Bienaime's former spouse will receive approximately 70% of the net proceeds from the shares sold in this transaction pursuant to a marital separation agreement between her and Mr. Bienaime. |
| 2 | Common | Common Stock | 2022-04-14 | S | D | 10,000 | $83.66 | 334,983 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on December 9, 2021, as amended on March 11, 2022. Mr. Bienaime's former spouse will receive approximately 70% of the net proceeds from the shares sold in this transaction pursuant to a marital separation agreement between her and Mr. Bienaime. |
| 3 | Derivative | Stock Option (Right to buy Common Stock) | 2022-04-14 | M | D | 10,000 | $0.00 | 75,000 | D | $37.46 · 2012-11-08 to 2022-05-07 | 10,000 Common Stock | (F1) Trade made pursuant to a 10b5-1 plan executed on December 9, 2021, as amended on March 11, 2022. Mr. Bienaime's former spouse will receive approximately 70% of the net proceeds from the shares sold in this transaction pursuant to a marital separation agreement between her and Mr. Bienaime. (F2) Reflects the number of options outstanding after the transactions from this specific stock option grant. |